Literature DB >> 14364382

Clinical uses of rauwolfia. I. In arterial hypertension.

J GENEST, L ADAMKIEWICZ, R ROBILLARD, G TREMBLAY.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; MOUTH/diseases; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 14364382      PMCID: PMC1825776     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Clinical uses of rauwolfia. II. In psoriasis and in constitutional leanness.

Authors:  J GENEST; L ADAMKIEWICZ; R ROBILLARD; G TREMBLAY
Journal:  Can Med Assoc J       Date:  1955-04-01       Impact factor: 8.262

2.  Treatment of hypertension with Rauwolfia serpentina alone and combined with other drugs: results in eighty-four cases.

Authors:  W R LIVESAY; J H MOYER; S I MILLER
Journal:  J Am Med Assoc       Date:  1954-07-17

3.  [Reserpin, the sedative principle from Rauwolfia serpentina B].

Authors:  J M MULLER; E SCHLITTLER; H J BEIN
Journal:  Experientia       Date:  1952-09-15

4.  The use of Rauwolfia serpentina in hypertensive patients.

Authors:  R W WILKINS; W E JUDSON
Journal:  N Engl J Med       Date:  1953-01-08       Impact factor: 91.245

5.  Pharmacology of Rauwolfia alkaloids, including reserpine.

Authors:  A J PLUMMER; A EARL; J A SCHNEIDER; J TRAPOLD; W BARRETT
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

6.  A clinical trial of Rauwolfia serpentina in essential hypertension.

Authors:  R J VAKIL
Journal:  Br Heart J       Date:  1949-10
  6 in total
  4 in total

1.  Clinical uses of rauwolfia. II. In psoriasis and in constitutional leanness.

Authors:  J GENEST; L ADAMKIEWICZ; R ROBILLARD; G TREMBLAY
Journal:  Can Med Assoc J       Date:  1955-04-01       Impact factor: 8.262

2.  Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases.

Authors:  G LEMIEUX; A DAVIGNON; J GENEST
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

3.  Psychosis and enhanced anxiety produced by reserpine and chlorpromazine.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

4.  Treatment of arterial hypertension with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina.

Authors:  G LEMIEUX; A DAVIGNON; J GENEST
Journal:  Can Med Assoc J       Date:  1956-01-15       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.